Development of a Dihydroquinoline–Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the <i>N</i>-Methyl-<scp>d</scp>-aspartate Receptor-Reference-Cited by-同舟云学术

Development of a Dihydroquinoline–Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the N-Methyl-d-aspartate Receptor

Published:2023-08-11 Issue:17 Volume:14 Page:3059-3076
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

D’Erasmo Michael P.¹,Akins Nicholas S.¹^ORCID,Ma Peipei¹,Jing Yao¹,Swanger Sharon A.²,Sharma Savita K.¹,Bartsch Perry W.¹,Menaldino David S.¹,Arcoria Paul J.¹,Bui Thi-Thien³,Pons-Bennaceur Alexandre³,Le Phuong²,Allen James P.²,Ullman Elijah Z.²,Nocilla Kelsey A.²,Zhang Jing²,Perszyk Riley E.²,Kim Sukhan²,Acker Timothy M.¹,Taz Azmain¹,Burton Samantha L.¹,Coe Kevin⁴^ORCID,Fritzemeier Russell G.¹,Burnashev Nail³,Yuan Hongjie²,Liotta Dennis C.¹^ORCID,Traynelis Stephen F.²^ORCID

Affiliation:

1. Department of Chemistry, Emory University, Atlanta, Georgia 30322, United States

2. Department of Pharmacology and Chemical Biology, Emory University, Atlanta, Georgia 30322, United States

3. INMED, INSERM, Aix Marseille University, 13284 Marseille, France

4. Janssen Research & Development, LLC, San Diego, California 92121, United States

Funder

Janssen Research and Development

National Institute of Neurological Disorders and Stroke

National Institute of Child Health and Human Development

National Institute on Aging

Brain Research Foundation

Publisher